The Company Evaxion Biotech A/S (United States), is listed on Nasdaq with a market value of $ 28.16 Millions, having an equity of $ 17.04 Millions.
With a total of 35 employees, the company is listed in the sector of Services and categorized in industry of Commercial Services.
In the last 12 months the Company had a revenue of $ 7.53 Millions, which generated a loss in the amount of $ -7.71 Millions.
As for its main indicators, the Company has a P/E ratio of -3.65, a P/BV ratio of 1.65 and in the last 12 months the Company did not pay dividends.
The Company is traded internationally through the ticker EVAX.